Table 3.
Variables | FEMD | RMD | Control | Final ART-analysisa p-value FEMD/RMD/C |
Post-hoc ART-analysisa p-FEMD/C |
Post-hoc ART-analysisa p-RMD/C |
Post-hoc ART-analysisa p-RMD/FEMD |
---|---|---|---|---|---|---|---|
Neutrophils-T0b | 4.22 (3.43;5.37;81) | 4.52 (3.42;5.39;46) | 3.37 (2.66;4.40;128) | 0.010 | 0.034 | 0.034 | 0.374 |
Neutrophils-T6b | 3.79 (3.02;5.06;62) | 3.87 (3.12;5.31;35) | – | 0.803 | |||
T0–T6 p-value | 0.104 | 0.134 | |||||
Eosinophils-T0b | 0.14 (0.07;0.20;81) | 0.14 (0.07;0.20;44) | 0.15 (0.10;0.26;128) | 0.003 | 0.005 | 0.004 | 0.679 |
Eosinophils-T6b | 0.20 (0.12;0.32;62) | 0.13 (0.08;0.20;34) | – | 0.676 | |||
T0–T6 p-value | 0.011* | 0.572 | |||||
Basophils-T0b | 0.05 (0.00;0.07;81) | 0 (0;0.07;44) | 0.05 (0;0.07;128) | 0.445 | 0.518 | 0.470 | 0.470 |
Basophils-T6b | 0.05 (0.00;0.07;62) | 0 (0;0.07;34) | – | 0.676 | |||
T0–T6 p-value | 0.408 | 0.975 | |||||
Monocytes-T0b | 0.45 (0.32;0.61;78) | 0.41 (0.32;0.56;44) | 0.40 (0.32;0.50;128) | 0.519 | 0.560 | 0.732 | 0.732 |
Monocytes-T6b | 0.43 (0.34;0.54;60) | 0.45 (0.33;0.58;35) | – | 0.676 | |||
T0–T6 p-value | 0.298 | 0.720 | |||||
Lymphocytes-T0b | 2.08 (1.66;2.52;81) | 2.48 (1.93;2.96;46) | 1.90 (1.52;2.38;128) | 0.005 | 0.492 | 0.003 | 0.012 |
Lymphocytes-T6b | 2.27 (1.77;2.69;62) | 2.24 (1.92;2.55;35) | – | 0.785 | |||
T0–T6 p-value | 0.104 | 0.171 | |||||
CRP-T0 (mg/L) | 3.61 (1.00;4.00;82) | 2.00 (1.00;4.00;45) | 1.00 (0.60;2.65;129) | < 0.001 | < 0.001 | 0.021 | 0.260 |
CRP-T6 (mg/L) | 1.75 (0.70;4.00;62) | 1.90 (0.80;4.00;32) | – | 0.676 | |||
T0–T6 p-value | 0.199 | 0.975 | |||||
Neutrophil/lymphocyte-T0 | 2.00 (1.53;2.77;81) | 1.67 (1.38;2.32;46) | 1.80 (1.37;2.25;128) | 0.164 | 0.129 | 0.637 | 0.129 |
Neutrophil/lymphocyte-T6 | 1.78 (1.28;2.62;62) | 1.76 (1.46;2.20;35) | – | 0.929 | |||
T0–T6 p-value | 0.032 | 0.835 | |||||
Monocyte/lymphocyte-T0 | 0.23 (0.15;0.32;78) | 0.20 (0.14;0.25;44) | 0.21 (0.16;0.28;128) | 0.164 | 0.442 | 0.442 | 0.418 |
Monocyte/lymphocyte-T6 | 0.20 (0.15;0.26;60) | 0.23 (0.15;0.28;35) | – | 0.685 | |||
T0–T6 p-value | 0.032 | 0.146 |
Complementary neutrophil:lymphocyte and monocyte:lymphocyte ratios are displayed in the lower part of this table (for interested readers)
Data are presented as median (quartile 1; quartile 3; sample size)
CRP C-reactive protein
Significant p-values are highlighted in bold font
aFinal ART-analyses with relevant covariates smoking, BMI, gender (from Table 2)
b×109/L